<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04150224</url>
  </required_header>
  <id_info>
    <org_study_id>PBTZ169-Z00-C01-3</org_study_id>
    <nct_id>NCT04150224</nct_id>
  </id_info>
  <brief_title>Safety, Tolerability, Pharmacokinetics and Food Effects Study of PBTZ169</brief_title>
  <official_title>An Open-label, Prospective Study of Safety, Tolerability, Pharmacokinetics and Food Effects of PBTZ169, 80 mg Capsules, When Used in Ascending Doses in Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nearmedic Plus LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nearmedic Plus LLC</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Open-label prospective non-comparative ascending dose randomized cohort study of single and
      multiple oral administration of PBTZ169 (capsules 80 mg) in healthy volunteers
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Open-label prospective non-comparativerandomized cohort study of safety, tolerability,
      pharmacokinetics and the effect of food of PBTZ169 in adult healthy volunteers after single
      and multiple oral administration. Study was conducted in one study center in the Russian
      Federation. The study included two stages:

      Stage 1 - single or double oral administration with dose escalation (fasted/after meal) in 5
      cohorts 10 healthy volunteers each plus 5 back-up volunteers;

      Stage 2 - multiple oral administration once a day after meal for 14 days in 1 cohort of 10
      healthy volunteers.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 3, 2018</start_date>
  <completion_date type="Actual">February 1, 2019</completion_date>
  <primary_completion_date type="Actual">November 23, 2018</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Adverse Events</measure>
    <time_frame>Up to last visit time point: C2, C3, C4 up to Day 7; C1 up to Day 13; C5 up to Day 21 after first drug intake</time_frame>
    <description>Safety and tolerability: number of (S)AEs</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Subjects With AEs</measure>
    <time_frame>Up to last visit time point: C2, C3, C4 up to Day 7; C1 up to Day 13; C5 up to Day 21 after first drug intake</time_frame>
    <description>Safety and tolerability: number of subjects with adverse events</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>CS Changes in Vital Signs</measure>
    <time_frame>Up to last visit time point: C2, C3, C4 up to Day 7; C1 up to Day 13; C5 up to Day 21 after first drug intake</time_frame>
    <description>Safety and tolerability:Clinically significant changes in vital signs (blood pressure, HR, body temperature, RR)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ECG Results (Safety and Tolerability)</measure>
    <time_frame>Up to last visit time point: C2, C3, C4 up to Day 7; C1 up to Day 13; C5 up to Day 21 after first drug intake</time_frame>
    <description>Clinically significant abnormal deviations in ECG findings</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Laboratory Examinations Results (Safety and Tolerability)</measure>
    <time_frame>Up to last visit time point: C2, C3, C4 up to Day 7; C1 up to Day 13; C5 up to Day 21 after first drug intake</time_frame>
    <description>Complete blood count, biochemical blood test, urine analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Results of Physical Examination: CS Deviations</measure>
    <time_frame>Up to last visit time point: C2, C3, C4 up to Day 7; C1 up to Day 13; C5 up to Day 21 after first drug intake</time_frame>
    <description>Safety and tolerability: number of physical examinations with CS deviations in results</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak Plasma Concentration (Сmax)</measure>
    <time_frame>In the dosing interval (up to 72 hours after the last drug administration)</time_frame>
    <description>Сmax of PBTZ169 at the timepoints:
C1A, C1B, C2 and C4: point 0 (-5 min to -1 min), 0:30, 1:00, 1:30, 2:00, 3:00, 4:00, 6:00, 9:00, 12:00, 24:00, 48:00 and 72:00 (h:min).
C3 (two administrations): point 0 (-5 min to -1 min), 0:30, 1:00, 1:30, 2:00, 3:00, 4:00, 6:00, 9:00, 12:00 (the point before the second administration from -5 min to -1 min), 12:30, 13:00, 13:30, 14:00, 15:00, 16:00, 18:00, 21:00, 24:00, 48:00 , 72:00 (h:min) after the first administration of the medicinal product.
C5 (14 days of intake): 5 minutes before the administration (only until the first dose), 0 min and within 24 h after the administration of the 1st, 7th and last (14th) dose: 0:15, 0:30, 1:00, 1:30, 2:00, 3:00, 4:00, 6:00, 8:00, 10:00, 12:00, 24:00 (h:min after the administration of a dose of the medicinal product); at 48 h and 72 h points after the last (14th) dose of PBTZ169</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Trough Concentration With Repeated Administration (Ctrough)</measure>
    <time_frame>Up to 72 hours after the last drug administration</time_frame>
    <description>PBTZ169 concentration before drug intake (Days 2 - 15)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Reach Maximum Concentration (Tmax)</measure>
    <time_frame>Up to 72 hours after the last drug administration</time_frame>
    <description>Cohort 3: Tmax relative to the time of administration in any dosage interval</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma Half-life Time (T1/2)</measure>
    <time_frame>Up to 72 hours after the last drug administration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area Under the Concentration-time Curve (AUC0 t)</measure>
    <time_frame>Up to 72 hours after the last drug administration</time_frame>
    <description>In the time interval from 0 to time (t) when the last blood sample is collected with a concentration above the limit of quantification.
C5: for the data of Day 14 based on measurements within 72 hours after the last dose administration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area Under the Concentration-time Curve (AUC0-∞)</measure>
    <time_frame>Up to 72 hours after the last drug administration</time_frame>
    <description>In the time interval from 0 to infinity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area Under the Concentration-time Curve (AUC0-24)</measure>
    <time_frame>In the dosing interval (up to 24 hours after drug administration)</time_frame>
    <description>C5 (multiple administration once a day for 14 days): AUC0-24 was calculated based on measurements within 24 hours after PBTZ169 intake</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Clearance (Clt/F)</measure>
    <time_frame>Up to 72 hours after the last drug administration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume of Distribution (Vd/F)</measure>
    <time_frame>Up to 72 hours after the last drug administration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Elimination Constant Kel</measure>
    <time_frame>Up to 72 hours after the last drug administration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relative Bioavailability</measure>
    <time_frame>Up to 72 hours after the last drug administration</time_frame>
    <description>f=AUC0-∞(T)/AUC0-∞(R); f'=AUC0-t(T)/AUC0-t(R) Test (T) - PBTZ169 640 mg after meals, reference (R) - PBTZ169 640 mg fasted</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relative Degree of Absorption</measure>
    <time_frame>Up to 72 hours after the last drug administration</time_frame>
    <description>f&quot;=Cmax(T)/Cmax(R). Test (T) - PBTZ169 640 mg after meals, reference (R) - PBTZ169 640 mg fasted</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Subjects With CS Changes in Vital Signs</measure>
    <time_frame>Up to last visit time point: C2, C3, C4 up to Day 7; C1 up to Day 13; C5 up to Day 21 after first drug intake</time_frame>
    <description>Safety and tolerability: No. of sbjs with clinically significant changes in vital signs (blood pressure, HR, body temperature, RR)</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Healthy Subjects</condition>
  <arm_group>
    <arm_group_label>Cohort 1 (C1A), PBTZ169</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Two doses of PBTZ169: 640 mg OD fasted and 640 mg OD after meal. Wash-out period ≥6 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 1 (C1B), PBTZ169</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Two doses of PBTZ169: 640 mg OD after meal and 640 OD mg fasted. Wash-out period ≥6 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 2 (C2), PBTZ169</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single dose of PBTZ169: 960 mg fasted</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 3 (C3), PBTZ169</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Two doses of PBTZ169: 640 mg twice a day (fasted) with a 12-hour interval; total daily dose - 1280 mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 4 (C4), PBTZ169</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single dose of PBTZ169: 1280 mg fasted</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 5 (C5), PBTZ169</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Multiple administration of PBTZ169: 1280 mg once a day after meal for 14 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PBTZ169 640 mg OD</intervention_name>
    <description>Two administrations once a day with a wash-out period: food effect</description>
    <arm_group_label>Cohort 1 (C1A), PBTZ169</arm_group_label>
    <arm_group_label>Cohort 1 (C1B), PBTZ169</arm_group_label>
    <other_name>Macozinone (PBTZ169)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PBTZ169 640 mg BiD</intervention_name>
    <description>Twice a day fasted; 1 day of administration</description>
    <arm_group_label>Cohort 3 (C3), PBTZ169</arm_group_label>
    <other_name>Macozinone (PBTZ169)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PBTZ169 960 mg SD</intervention_name>
    <description>Once a day fasted</description>
    <arm_group_label>Cohort 2 (C2), PBTZ169</arm_group_label>
    <other_name>Macozinone (PBTZ169)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PBTZ169 1280 mg SD</intervention_name>
    <description>Once a day fasted</description>
    <arm_group_label>Cohort 4 (C4), PBTZ169</arm_group_label>
    <other_name>Macozinone (PBTZ169)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PBTZ169 1280 mg MD</intervention_name>
    <description>Once a day after meal, 14 doses</description>
    <arm_group_label>Cohort 5 (C5), PBTZ169</arm_group_label>
    <other_name>Macozinone (PBTZ169)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Written informed consent from the volunteer.

          2. Men and women aged 18-45 years, inclusive.

          3. Body mass index of 18.5-30 kg/m2.

          4. Verified &quot;healthy&quot; diagnosis based on physical examination, vital signs, standard
             laboratory tests (complete blood count and biochemical blood test, urine analysis) and
             instrumental tests (ECG, fluorography examination or X-ray examination).

          5. Negative results of tests for human immunodeficiency virus (HIV), syphilis, hepatitis
             B (Hbs Ag) and hepatitis C (antibodies to HCV).

          6. Ability to comply with all the requirements of the protocol in the opinion of the
             investigator.

          7. Consent of the participant and his/her partner to use reliable contraceptive methods
             during the study and within 90 days after the end of their participation. A reliable
             method of contraception is a combination of a male condom with at least one of the
             following methods:

               -  hormonal contraceptives used by the male's partner (only if she does not
                  participate in this clinical study);

               -  use of aerosols, creams, suppositories and other agents containing spermicides;

               -  use of intrauterine device by female partner.

        Exclusion Criteria:

          1. History of allergies, including at least one episode of allergy to medications.

          2. Chronic diseases of the cardiovascular, bronchopulmonary, neuroendocrine systems, ENT,
             as well as diseases of the gastrointestinal tract, liver, kidneys, blood, skin.

          3. Hypolactasia (lactose intolerance, lactase deficiency) or glucose-galatose
             malabsorption in medical history.

          4. Chronic eye diseases except for myopia, hypermetropia and astigmatism of mild and
             moderate severity.

          5. Surgeries on the gastrointestinal tract (except for appendectomy done more than 1 year
             before screening).

          6. Regular administration or use (including externally) of hormonal agent for more than 1
             week less than 45 days before screening

          7. Regular administration of medicinal products less than 4 weeks before screening.

          8. Use of medicinal products that have a pronounced effect on liver function or
             hemodynamics (barbiturates, omeprazole, cimetidine, etc.) less than 30 days before
             screening.

          9. Positive test for narcotics and psychotropic products.

         10. Blood pressure after resting in supine position for at least 5 minutes above 130 mm Hg
             (systolic blood pressure) and 90 mm Hg (diastolic blood pressure) or below 110 mm Hg
             (systolic blood pressure) and 60 mm Hg (diastolic blood pressure).

         11. Heart rate (according to ECG) after resting in supine position for at least 5 minutes
             above 90 bpm or below 60 bpm.

         12. Blood donation (450 mL of blood or plasma and more) less than 3 months before the
             screening.

         13. Acute infectious diseases less than 4 weeks before screening.

         14. Administration of more than 10 units of alcohol per week (1 unit of alcohol is
             equivalent to 500 mL of beer, 200 mL of wine or 50 mL of a spirit) or history of
             alcoholism, drug abuse, substance abuse.

         15. Mental diseases.

         16. Smoking for three months before screening.

         17. Participation in any clinical study less than 3 months before screening.

         18. Planned conception or sperm donation during the study after the administration of the
             investigational product or within 3 months after the last administration of the
             product.

         19. Positive pregnancy test for women.

         20. Breastfeeding period.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Clinical hospital at the Yaroslavl station of the Open Joint Stock Company Russian Railways</name>
      <address>
        <city>Yaroslavl</city>
        <zip>150030</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>October 18, 2019</study_first_submitted>
  <study_first_submitted_qc>October 31, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 4, 2019</study_first_posted>
  <results_first_submitted>January 24, 2020</results_first_submitted>
  <results_first_submitted_qc>February 13, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">February 28, 2020</results_first_posted>
  <last_update_submitted>February 13, 2020</last_update_submitted>
  <last_update_submitted_qc>February 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>PBTZ169</keyword>
  <keyword>Macozinone</keyword>
  <keyword>Antimycobacterial</keyword>
  <keyword>Tuberculosis</keyword>
  <keyword>Drug Resistant Tubercolosis</keyword>
  <keyword>MDR-TB</keyword>
  <keyword>XDR-TB</keyword>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 11, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/24/NCT04150224/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Period 1: Single or double dosing (Cohorts 1-4) Period 2: Multiple dosing (Cohort 5)</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Cohort 1 (C1A), PBTZ169</title>
          <description>Two doses of PBTZ169: 640 mg OD fasted and 640 mg OD after meal. Wash-out period ≥6 days.
PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
        </group>
        <group group_id="P2">
          <title>Cohort 1 (C1B), PBTZ169</title>
          <description>Two doses of PBTZ169: 640 mg OD after meal and 640 OD mg fasted. Wash-out period ≥6 days.
PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
        </group>
        <group group_id="P3">
          <title>Cohort 2 (C2), PBTZ169</title>
          <description>Single dose of PBTZ169: 960 mg fasted
PBTZ169 960 mg SD: Once a day fasted</description>
        </group>
        <group group_id="P4">
          <title>Cohort 3 (C3), PBTZ169</title>
          <description>Two doses of PBTZ169: 640 mg twice a day (fasted) with a 12-hour interval; total daily dose – 1280 mg
PBTZ169 640 mg BiD: Twice a day fasted; 1 day of administration</description>
        </group>
        <group group_id="P5">
          <title>Cohort 4 (C4), PBTZ169</title>
          <description>Single dose of PBTZ169: 1280 mg fasted
PBTZ169 1280 mg SD: Once a day fasted</description>
        </group>
        <group group_id="P6">
          <title>Cohort 5 (C5), PBTZ169</title>
          <description>Multiple administration of PBTZ169: 1280 mg once a day after meal for 14 days
PBTZ169 1280 mg MD: Once a day after meal, 14 doses</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10">10 healthy volunteers receiving PBTZ169 + 1 backup volunteer</participants>
                <participants group_id="P2" count="10">10 healthy volunteers receiving PBTZ169 + 1 backup volunteer</participants>
                <participants group_id="P3" count="10">10 healthy volunteers receiving PBTZ169 + 1 backup volunteer</participants>
                <participants group_id="P4" count="10">10 healthy volunteers receiving PBTZ169 + 1 backup volunteer</participants>
                <participants group_id="P5" count="10">10 healthy volunteers receiving PBTZ169 + 1 backup volunteer</participants>
                <participants group_id="P6" count="10">Period 2: Multple Dosing</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="10"/>
                <participants group_id="P4" count="10"/>
                <participants group_id="P5" count="10"/>
                <participants group_id="P6" count="10">Period 2: Multple Dosing</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Cohort 1 (C1A), PBTZ169</title>
          <description>Two doses of PBTZ169: 640 mg OD fasted and 640 mg OD after meal. Wash-out period ≥6 days.
PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
        </group>
        <group group_id="B2">
          <title>Cohort 1 (C1B), PBTZ169</title>
          <description>Two doses of PBTZ169: 640 mg OD after meal and 640 OD mg fasted. Wash-out period ≥6 days.
PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
        </group>
        <group group_id="B3">
          <title>Cohort 2 (C2), PBTZ169</title>
          <description>Single dose of PBTZ169: 960 mg fasted
PBTZ169 960 mg SD: Once a day fasted</description>
        </group>
        <group group_id="B4">
          <title>Cohort 3 (C3), PBTZ169</title>
          <description>Two doses of PBTZ169: 640 mg twice a day (fasted) with a 12-hour interval; total daily dose – 1280 mg
PBTZ169 640 mg BiD: Twice a day fasted; 1 day of administration</description>
        </group>
        <group group_id="B5">
          <title>Cohort 4 (C4), PBTZ169</title>
          <description>Single dose of PBTZ169: 1280 mg fasted
PBTZ169 1280 mg SD: Once a day fasted</description>
        </group>
        <group group_id="B6">
          <title>Cohort 5 (C5), PBTZ169</title>
          <description>Multiple administration of PBTZ169: 1280 mg once a day after meal for 14 days
PBTZ169 1280 mg MD: Once a day after meal, 14 doses</description>
        </group>
        <group group_id="B7">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="10"/>
            <count group_id="B4" value="10"/>
            <count group_id="B5" value="10"/>
            <count group_id="B6" value="10"/>
            <count group_id="B7" value="60"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="10"/>
                    <measurement group_id="B6" value="10"/>
                    <measurement group_id="B7" value="60"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.2" spread="5.25"/>
                    <measurement group_id="B2" value="23.0" spread="2.26"/>
                    <measurement group_id="B3" value="23.7" spread="3.95"/>
                    <measurement group_id="B4" value="27.1" spread="5.09"/>
                    <measurement group_id="B5" value="30.1" spread="9.10"/>
                    <measurement group_id="B6" value="26.7" spread="5.01"/>
                    <measurement group_id="B7" value="26.3" spread="5.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="4"/>
                    <measurement group_id="B6" value="6"/>
                    <measurement group_id="B7" value="32"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="6"/>
                    <measurement group_id="B6" value="4"/>
                    <measurement group_id="B7" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="10"/>
                    <measurement group_id="B6" value="10"/>
                    <measurement group_id="B7" value="60"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="00"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Adverse Events</title>
        <description>Safety and tolerability: number of (S)AEs</description>
        <time_frame>Up to last visit time point: C2, C3, C4 up to Day 7; C1 up to Day 13; C5 up to Day 21 after first drug intake</time_frame>
        <population>Safety population</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 1 (C1A+C1B), PBTZ169</title>
            <description>Two doses of PBTZ169: 640 mg OD fasted/after meal and 640 mg OD after meal/fasted. Wash-out period ≥6 days.
PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
          </group>
          <group group_id="O2">
            <title>Cohort 2 (C2), PBTZ169</title>
            <description>Single dose of PBTZ169: 960 mg fasted
PBTZ169 960 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O3">
            <title>Cohort 3 (C3), PBTZ169</title>
            <description>Two doses of PBTZ169: 640 mg twice a day (fasted) with a 12-hour interval; total daily dose – 1280 mg
PBTZ169 640 mg BiD: Twice a day fasted; 1 day of administration</description>
          </group>
          <group group_id="O4">
            <title>Cohort 4 (C4), PBTZ169</title>
            <description>Single dose of PBTZ169: 1280 mg fasted
PBTZ169 1280 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O5">
            <title>Cohort 5 (C5), PBTZ169</title>
            <description>Multiple administration of PBTZ169: 1280 mg once a day after meal for 14 days
PBTZ169 1280 mg MD: Once a day after meal, 14 doses</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Adverse Events</title>
          <description>Safety and tolerability: number of (S)AEs</description>
          <population>Safety population</population>
          <units>AEs</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
                <count group_id="O5" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Number of AEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Number of SAEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Number of drug-related AEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Drug-related &quot;Cardiac disorders&quot; AEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Drug-related &quot;GastroInt.&quot; AEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Drug-related &quot;Investigations&quot; AEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Drug-related &quot;Nervous syst.&quot; AEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Drug-related &quot;Metabolic&quot; AEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Subjects With AEs</title>
        <description>Safety and tolerability: number of subjects with adverse events</description>
        <time_frame>Up to last visit time point: C2, C3, C4 up to Day 7; C1 up to Day 13; C5 up to Day 21 after first drug intake</time_frame>
        <population>Safety population</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 1 (C1A+C1B), PBTZ169</title>
            <description>Two doses of PBTZ169: 640 mg OD fasted/after meal and 640 mg OD after meal/fasted. Wash-out period ≥6 days.
PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
          </group>
          <group group_id="O2">
            <title>Cohort 2 (C2), PBTZ169</title>
            <description>Single dose of PBTZ169: 960 mg fasted
PBTZ169 960 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O3">
            <title>Cohort 3 (C3), PBTZ169</title>
            <description>Two doses of PBTZ169: 640 mg twice a day (fasted) with a 12-hour interval; total daily dose – 1280 mg
PBTZ169 640 mg BiD: Twice a day fasted; 1 day of administration</description>
          </group>
          <group group_id="O4">
            <title>Cohort 4 (C4), PBTZ169</title>
            <description>Single dose of PBTZ169: 1280 mg fasted
PBTZ169 1280 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O5">
            <title>Cohort 5 (C5), PBTZ169</title>
            <description>Multiple administration of PBTZ169: 1280 mg once a day after meal for 14 days
PBTZ169 1280 mg MD: Once a day after meal, 14 doses</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With AEs</title>
          <description>Safety and tolerability: number of subjects with adverse events</description>
          <population>Safety population</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
                <count group_id="O5" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Number of sbjs with AEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Number of sbjs with drug-related AEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>CS Changes in Vital Signs</title>
        <description>Safety and tolerability:Clinically significant changes in vital signs (blood pressure, HR, body temperature, RR)</description>
        <time_frame>Up to last visit time point: C2, C3, C4 up to Day 7; C1 up to Day 13; C5 up to Day 21 after first drug intake</time_frame>
        <population>Safety population</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 1 (C1A), PBTZ169</title>
            <description>Two doses of PBTZ169: 640 mg OD fasted and 640 mg OD after meal. Wash-out period ≥6 days.
PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
          </group>
          <group group_id="O2">
            <title>Cohort 1 (C1B), PBTZ169</title>
            <description>Two doses of PBTZ169: 640 mg OD after meal and 640 OD mg fasted. Wash-out period ≥6 days.
PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
          </group>
          <group group_id="O3">
            <title>Cohort 2 (C2), PBTZ169</title>
            <description>Single dose of PBTZ169: 960 mg fasted
PBTZ169 960 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O4">
            <title>Cohort 3 (C3), PBTZ169</title>
            <description>Two doses of PBTZ169: 640 mg twice a day (fasted) with a 12-hour interval; total daily dose – 1280 mg
PBTZ169 640 mg BiD: Twice a day fasted; 1 day of administration</description>
          </group>
          <group group_id="O5">
            <title>Cohort 4 (C4), PBTZ169</title>
            <description>Single dose of PBTZ169: 1280 mg fasted
PBTZ169 1280 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O6">
            <title>Cohort 5 (C5), PBTZ169</title>
            <description>Multiple administration of PBTZ169: 1280 mg once a day after meal for 14 days
PBTZ169 1280 mg MD: Once a day after meal, 14 doses</description>
          </group>
        </group_list>
        <measure>
          <title>CS Changes in Vital Signs</title>
          <description>Safety and tolerability:Clinically significant changes in vital signs (blood pressure, HR, body temperature, RR)</description>
          <population>Safety population</population>
          <units>No of cases of CS changes in vital signs</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CS Changes in blood pressure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS changes in HH: Sinus tachycardia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS Changes in Temperature</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS Changes in RR</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>ECG Results (Safety and Tolerability)</title>
        <description>Clinically significant abnormal deviations in ECG findings</description>
        <time_frame>Up to last visit time point: C2, C3, C4 up to Day 7; C1 up to Day 13; C5 up to Day 21 after first drug intake</time_frame>
        <population>Safety population</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 1 (C1A), PBTZ169</title>
            <description>Two doses of PBTZ169: 640 mg OD fasted and 640 mg OD after meal. Wash-out period ≥6 days.
PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
          </group>
          <group group_id="O2">
            <title>Cohort 1 (C1B), PBTZ169</title>
            <description>Two doses of PBTZ169: 640 mg OD after meal and 640 OD mg fasted. Wash-out period ≥6 days.
PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
          </group>
          <group group_id="O3">
            <title>Cohort 2 (C2), PBTZ169</title>
            <description>Single dose of PBTZ169: 960 mg fasted
PBTZ169 960 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O4">
            <title>Cohort 3 (C3), PBTZ169</title>
            <description>Two doses of PBTZ169: 640 mg twice a day (fasted) with a 12-hour interval; total daily dose – 1280 mg
PBTZ169 640 mg BiD: Twice a day fasted; 1 day of administration</description>
          </group>
          <group group_id="O5">
            <title>Cohort 4 (C4), PBTZ169</title>
            <description>Single dose of PBTZ169: 1280 mg fasted
PBTZ169 1280 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O6">
            <title>Cohort 5 (C5), PBTZ169</title>
            <description>Multiple administration of PBTZ169: 1280 mg once a day after meal for 14 days
PBTZ169 1280 mg MD: Once a day after meal, 14 doses</description>
          </group>
        </group_list>
        <measure>
          <title>ECG Results (Safety and Tolerability)</title>
          <description>Clinically significant abnormal deviations in ECG findings</description>
          <population>Safety population</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Electrocardiogram repolarisation abnormality</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sinus tachycardia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Electrocardiogram abnormal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Defect conduction intraventricular</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Laboratory Examinations Results (Safety and Tolerability)</title>
        <description>Complete blood count, biochemical blood test, urine analysis</description>
        <time_frame>Up to last visit time point: C2, C3, C4 up to Day 7; C1 up to Day 13; C5 up to Day 21 after first drug intake</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cohort 1 (C1A), PBTZ169</title>
            <description>Two doses of PBTZ169: 640 mg OD fasted and 640 mg OD after meal. Wash-out period ≥6 days.
PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
          </group>
          <group group_id="O2">
            <title>Cohort 1 (C1B), PBTZ169</title>
            <description>Two doses of PBTZ169: 640 mg OD after meal and 640 OD mg fasted. Wash-out period ≥6 days.
PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
          </group>
          <group group_id="O3">
            <title>Cohort 2 (C2), PBTZ169</title>
            <description>Single dose of PBTZ169: 960 mg fasted
PBTZ169 960 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O4">
            <title>Cohort 3 (C3), PBTZ169</title>
            <description>Two doses of PBTZ169: 640 mg twice a day (fasted) with a 12-hour interval; total daily dose – 1280 mg
PBTZ169 640 mg BiD: Twice a day fasted; 1 day of administration</description>
          </group>
          <group group_id="O5">
            <title>Cohort 4 (C4), PBTZ169</title>
            <description>Single dose of PBTZ169: 1280 mg fasted
PBTZ169 1280 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O6">
            <title>Cohort 5 (C5), PBTZ169</title>
            <description>Multiple administration of PBTZ169: 1280 mg once a day after meal for 14 days
PBTZ169 1280 mg MD: Once a day after meal, 14 doses</description>
          </group>
        </group_list>
        <measure>
          <title>Laboratory Examinations Results (Safety and Tolerability)</title>
          <description>Complete blood count, biochemical blood test, urine analysis</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CS Blood glucose increase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS Hypercreatininaemia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS Anaemia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS Haemoglobin decreased</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS Thrombocytosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Results of Physical Examination: CS Deviations</title>
        <description>Safety and tolerability: number of physical examinations with CS deviations in results</description>
        <time_frame>Up to last visit time point: C2, C3, C4 up to Day 7; C1 up to Day 13; C5 up to Day 21 after first drug intake</time_frame>
        <population>Safety population</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 1 (C1A), PBTZ169</title>
            <description>Two doses of PBTZ169: 640 mg OD fasted and 640 mg OD after meal. Wash-out period ≥6 days.
PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
          </group>
          <group group_id="O2">
            <title>Cohort 1 (C1B), PBTZ169</title>
            <description>Two doses of PBTZ169: 640 mg OD after meal and 640 OD mg fasted. Wash-out period ≥6 days.
PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
          </group>
          <group group_id="O3">
            <title>Cohort 2 (C2), PBTZ169</title>
            <description>Single dose of PBTZ169: 960 mg fasted
PBTZ169 960 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O4">
            <title>Cohort 3 (C3), PBTZ169</title>
            <description>Two doses of PBTZ169: 640 mg twice a day (fasted) with a 12-hour interval; total daily dose – 1280 mg
PBTZ169 640 mg BiD: Twice a day fasted; 1 day of administration</description>
          </group>
          <group group_id="O5">
            <title>Cohort 4 (C4), PBTZ169</title>
            <description>Single dose of PBTZ169: 1280 mg fasted
PBTZ169 1280 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O6">
            <title>Cohort 5 (C5), PBTZ169</title>
            <description>Multiple administration of PBTZ169: 1280 mg once a day after meal for 14 days
PBTZ169 1280 mg MD: Once a day after meal, 14 doses</description>
          </group>
        </group_list>
        <measure>
          <title>Results of Physical Examination: CS Deviations</title>
          <description>Safety and tolerability: number of physical examinations with CS deviations in results</description>
          <population>Safety population</population>
          <units>CS physical examination deviations</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Peak Plasma Concentration (Сmax)</title>
        <description>Сmax of PBTZ169 at the timepoints:
C1A, C1B, C2 and C4: point 0 (-5 min to -1 min), 0:30, 1:00, 1:30, 2:00, 3:00, 4:00, 6:00, 9:00, 12:00, 24:00, 48:00 and 72:00 (h:min).
C3 (two administrations): point 0 (-5 min to -1 min), 0:30, 1:00, 1:30, 2:00, 3:00, 4:00, 6:00, 9:00, 12:00 (the point before the second administration from -5 min to -1 min), 12:30, 13:00, 13:30, 14:00, 15:00, 16:00, 18:00, 21:00, 24:00, 48:00 , 72:00 (h:min) after the first administration of the medicinal product.
C5 (14 days of intake): 5 minutes before the administration (only until the first dose), 0 min and within 24 h after the administration of the 1st, 7th and last (14th) dose: 0:15, 0:30, 1:00, 1:30, 2:00, 3:00, 4:00, 6:00, 8:00, 10:00, 12:00, 24:00 (h:min after the administration of a dose of the medicinal product); at 48 h and 72 h points after the last (14th) dose of PBTZ169</description>
        <time_frame>In the dosing interval (up to 72 hours after the last drug administration)</time_frame>
        <population>C1-4 - Single or double dose administration, C5 - Multiple administration for 14 days</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 1 (C1A+C1B), PBTZ169, Fasted</title>
            <description>PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
          </group>
          <group group_id="O2">
            <title>Cohort 1 (C1A+C1B), PBTZ169, After Meal</title>
            <description>PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
          </group>
          <group group_id="O3">
            <title>Cohort 2 (C2), PBTZ169</title>
            <description>Single dose of PBTZ169: 960 mg fasted
PBTZ169 960 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O4">
            <title>Cohort 3 (C3), PBTZ169</title>
            <description>Two doses of PBTZ169: 640 mg twice a day (fasted) with a 12-hour interval; total daily dose – 1280 mg
PBTZ169 640 mg BiD: Twice a day fasted; 1 day of administration</description>
          </group>
          <group group_id="O5">
            <title>Cohort 4 (C4), PBTZ169</title>
            <description>Single dose of PBTZ169: 1280 mg fasted
PBTZ169 1280 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O6">
            <title>Cohort 5 (C5), PBTZ169</title>
            <description>Multiple administration of PBTZ169: 1280 mg once a day after meal for 14 days
PBTZ169 1280 mg MD: Once a day after meals, 14 doses</description>
          </group>
        </group_list>
        <measure>
          <title>Peak Plasma Concentration (Сmax)</title>
          <description>Сmax of PBTZ169 at the timepoints:
C1A, C1B, C2 and C4: point 0 (-5 min to -1 min), 0:30, 1:00, 1:30, 2:00, 3:00, 4:00, 6:00, 9:00, 12:00, 24:00, 48:00 and 72:00 (h:min).
C3 (two administrations): point 0 (-5 min to -1 min), 0:30, 1:00, 1:30, 2:00, 3:00, 4:00, 6:00, 9:00, 12:00 (the point before the second administration from -5 min to -1 min), 12:30, 13:00, 13:30, 14:00, 15:00, 16:00, 18:00, 21:00, 24:00, 48:00 , 72:00 (h:min) after the first administration of the medicinal product.
C5 (14 days of intake): 5 minutes before the administration (only until the first dose), 0 min and within 24 h after the administration of the 1st, 7th and last (14th) dose: 0:15, 0:30, 1:00, 1:30, 2:00, 3:00, 4:00, 6:00, 8:00, 10:00, 12:00, 24:00 (h:min after the administration of a dose of the medicinal product); at 48 h and 72 h points after the last (14th) dose of PBTZ169</description>
          <population>C1-4 - Single or double dose administration, C5 - Multiple administration for 14 days</population>
          <units>ng/ml</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Before dosing</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.250" spread="0"/>
                    <measurement group_id="O2" value="0.250" spread="0"/>
                    <measurement group_id="O3" value="0.250" spread="0"/>
                    <measurement group_id="O4" value="0.250" spread="0"/>
                    <measurement group_id="O5" value="0.250" spread="0"/>
                    <measurement group_id="O6" value="0.250" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0.25 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="0.250" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0.5 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.701" spread="236.6"/>
                    <measurement group_id="O2" value="0.399" spread="199.6"/>
                    <measurement group_id="O3" value="19.351" spread="228.4"/>
                    <measurement group_id="O4" value="26.048" spread="131.0"/>
                    <measurement group_id="O5" value="24.576" spread="76.6"/>
                    <measurement group_id="O6" value="1.183" spread="864.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.131" spread="84.5"/>
                    <measurement group_id="O2" value="8.827" spread="415.1"/>
                    <measurement group_id="O3" value="45.729" spread="100.8"/>
                    <measurement group_id="O4" value="48.328" spread="46.8"/>
                    <measurement group_id="O5" value="74.711" spread="52.4"/>
                    <measurement group_id="O6" value="22.877" spread="3056.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.5 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.998" spread="108.3"/>
                    <measurement group_id="O2" value="59.226" spread="150.6"/>
                    <measurement group_id="O3" value="48.390" spread="81.1"/>
                    <measurement group_id="O4" value="45.679" spread="43.9"/>
                    <measurement group_id="O5" value="54.949" spread="66.3"/>
                    <measurement group_id="O6" value="109.319" spread="203.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.660" spread="118.4"/>
                    <measurement group_id="O2" value="95.641" spread="113.9"/>
                    <measurement group_id="O3" value="43.633" spread="145.2"/>
                    <measurement group_id="O4" value="23.782" spread="46.9"/>
                    <measurement group_id="O5" value="39.253" spread="73.4"/>
                    <measurement group_id="O6" value="162.170" spread="141.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.435" spread="106.4"/>
                    <measurement group_id="O2" value="90.330" spread="84.9"/>
                    <measurement group_id="O3" value="22.159" spread="167.4"/>
                    <measurement group_id="O4" value="11.438" spread="60.2"/>
                    <measurement group_id="O5" value="23.571" spread="75.4"/>
                    <measurement group_id="O6" value="128.518" spread="95.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.775" spread="96.4"/>
                    <measurement group_id="O2" value="88.719" spread="50.2"/>
                    <measurement group_id="O3" value="15.773" spread="184.0"/>
                    <measurement group_id="O4" value="6.593" spread="73.8"/>
                    <measurement group_id="O5" value="13.897" spread="79.0"/>
                    <measurement group_id="O6" value="110.614" spread="68.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.195" spread="75.3"/>
                    <measurement group_id="O2" value="31.083" spread="46.8"/>
                    <measurement group_id="O3" value="5.884" spread="171.9"/>
                    <measurement group_id="O4" value="3.461" spread="51.7"/>
                    <measurement group_id="O5" value="5.771" spread="73.0"/>
                    <measurement group_id="O6" value="68.001" spread="127.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="34.331" spread="149.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.827" spread="77.4"/>
                    <measurement group_id="O2" value="10.815" spread="71.3"/>
                    <measurement group_id="O3" value="2.672" spread="166.7"/>
                    <measurement group_id="O4" value="1.330" spread="39.1"/>
                    <measurement group_id="O5" value="2.880" spread="87.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="14.636" spread="93.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.144" spread="59.1"/>
                    <measurement group_id="O2" value="4.621" spread="55.6"/>
                    <measurement group_id="O3" value="1.944" spread="125.3"/>
                    <measurement group_id="O4" value="0.859" spread="51.7"/>
                    <measurement group_id="O5" value="1.440" spread="50.7"/>
                    <measurement group_id="O6" value="8.917" spread="73.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12.5 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O4" value="6.247" spread="270.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>13 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O4" value="26.515" spread="152.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>13.5 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O4" value="54.520" spread="65.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>14 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O4" value="41.996" spread="61.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>15 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O4" value="23.165" spread="64.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>16 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O4" value="13.113" spread="88.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O4" value="8.351" spread="127.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>21 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O4" value="3.590" spread="139.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.456" spread="106.1"/>
                    <measurement group_id="O2" value="1.428" spread="42.2"/>
                    <measurement group_id="O3" value="0.731" spread="85.5"/>
                    <measurement group_id="O4" value="1.763" spread="75.1"/>
                    <measurement group_id="O5" value="0.591" spread="55.8"/>
                    <measurement group_id="O6" value="4.695" spread="128.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.250" spread="0"/>
                    <measurement group_id="O2" value="0.385" spread="62.2"/>
                    <measurement group_id="O3" value="0.288" spread="47.1"/>
                    <measurement group_id="O4" value="0.383" spread="65.9"/>
                    <measurement group_id="O5" value="0.269" spread="23.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>72 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.250" spread="0"/>
                    <measurement group_id="O2" value="0.260" spread="18.3"/>
                    <measurement group_id="O3" value="0.250" spread="0"/>
                    <measurement group_id="O4" value="0.269" spread="23.3"/>
                    <measurement group_id="O5" value="0.250" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, before dosing</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="8.352" spread="102.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 0.25 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="8.424" spread="68.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 0.5 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="15.488" spread="86.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 1 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="102.727" spread="146.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 1.5 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="196.799" spread="124.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 2 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="247.253" spread="90.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 3 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="214.245" spread="53.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 4 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="163.523" spread="36.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 6 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="71.494" spread="75.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 8 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="34.724" spread="60.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 10 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="21.163" spread="62.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 12 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="13.464" spread="54.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, 24 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="6.509" spread="51.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14, befor dosing</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="7.657" spread="48.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14, 0.25 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="7.625" spread="50.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14, 0.5 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="12.027" spread="47.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14, 1 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="56.489" spread="185.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14, 1.5 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="150.856" spread="123.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14, 2 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="208.562" spread="56.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14, 3 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="205.471" spread="69.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14, 4 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="189.609" spread="39.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14, 6 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="81.751" spread="55.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14, 8 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="42.315" spread="67.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14, 10 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="28.824" spread="121.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14, 12 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="14.270" spread="48.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14, 24 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="6.040" spread="58.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14, 48 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="2.128" spread="103.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14, 72 h</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="0.360" spread="90.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Trough Concentration With Repeated Administration (Ctrough)</title>
        <description>PBTZ169 concentration before drug intake (Days 2 - 15)</description>
        <time_frame>Up to 72 hours after the last drug administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cohort 5 (C5), PBTZ169</title>
            <description>Multiple administration of PBTZ169: 1280 mg once a day after meal for 14 days
PBTZ169 1280 mg MD: Once a day after meals, 14 doses</description>
          </group>
        </group_list>
        <measure>
          <title>Trough Concentration With Repeated Administration (Ctrough)</title>
          <description>PBTZ169 concentration before drug intake (Days 2 - 15)</description>
          <units>ng/ml</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.695" spread="128.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.502" spread="39.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.243" spread="42.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.874" spread="51.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.585" spread="53.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.352" spread="102.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.509" spread="51.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 9</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.422" spread="51.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 10</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.664" spread="58.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 11</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.433" spread="48.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.006" spread="51.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 13</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.942" spread="44.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.657" spread="48.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.040" spread="58.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Reach Maximum Concentration (Tmax)</title>
        <description>Cohort 3: Tmax relative to the time of administration in any dosage interval</description>
        <time_frame>Up to 72 hours after the last drug administration</time_frame>
        <population>C1-4 - Single or double dose administration, C5 - Multiple administration for 14 days</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 1 (C1A+C1B), PBTZ169, Fasted</title>
            <description>PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
          </group>
          <group group_id="O2">
            <title>Cohort 1 (C1A+C1B), PBTZ169, After Meal</title>
            <description>PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
          </group>
          <group group_id="O3">
            <title>Cohort 2 (C2), PBTZ169</title>
            <description>Single dose of PBTZ169: 960 mg fasted
PBTZ169 960 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O4">
            <title>Cohort 3 (C3), PBTZ169</title>
            <description>Two doses of PBTZ169: 640 mg twice a day (fasted) with a 12-hour interval; total daily dose – 1280 mg
PBTZ169 640 mg BiD: Twice a day fasted; 1 day of administration</description>
          </group>
          <group group_id="O5">
            <title>Cohort 4 (C4), PBTZ169</title>
            <description>Single dose of PBTZ169: 1280 mg fasted
PBTZ169 1280 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O6">
            <title>Cohort 5 (C5), PBTZ169</title>
            <description>Multiple administration of PBTZ169: 1280 mg once a day after meal for 14 days
PBTZ169 1280 mg MD: Once a day after meals, 14 doses</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Reach Maximum Concentration (Tmax)</title>
          <description>Cohort 3: Tmax relative to the time of administration in any dosage interval</description>
          <population>C1-4 - Single or double dose administration, C5 - Multiple administration for 14 days</population>
          <units>h</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Dosing day / Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.73" spread="0.896"/>
                    <measurement group_id="O2" value="2.90" spread="0.912"/>
                    <measurement group_id="O3" value="1.65" spread="0.709"/>
                    <measurement group_id="O4" value="1.35" spread="0.747"/>
                    <measurement group_id="O5" value="1.15" spread="0.242"/>
                    <measurement group_id="O6" value="2.60" spread="1.410"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="2.25" spread="0.825"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="2.40" spread="1.022"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Plasma Half-life Time (T1/2)</title>
        <time_frame>Up to 72 hours after the last drug administration</time_frame>
        <population>C1-4 - Single or double dose administration, C5 - Multiple administration for 14 days</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 1 (C1A+C1B), PBTZ169, Fasted</title>
            <description>PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
          </group>
          <group group_id="O2">
            <title>Cohort 1 (C1A+C1B), PBTZ169, After Meal</title>
            <description>PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
          </group>
          <group group_id="O3">
            <title>Cohort 2 (C2), PBTZ169</title>
            <description>Single dose of PBTZ169: 960 mg fasted
PBTZ169 960 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O4">
            <title>Cohort 3 (C3), PBTZ169</title>
            <description>Two doses of PBTZ169: 640 mg twice a day (fasted) with a 12-hour interval; total daily dose – 1280 mg
PBTZ169 640 mg BiD: Twice a day fasted; 1 day of administration</description>
          </group>
          <group group_id="O5">
            <title>Cohort 4 (C4), PBTZ169</title>
            <description>Single dose of PBTZ169: 1280 mg fasted
PBTZ169 1280 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O6">
            <title>Cohort 5 (C5), PBTZ169</title>
            <description>Multiple administration of PBTZ169: 1280 mg once a day after meal for 14 days
PBTZ169 1280 mg MD: Once a day after meals, 14 doses</description>
          </group>
        </group_list>
        <measure>
          <title>Plasma Half-life Time (T1/2)</title>
          <population>C1-4 - Single or double dose administration, C5 - Multiple administration for 14 days</population>
          <units>h</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Dosing day / Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.46" spread="3.134"/>
                    <measurement group_id="O2" value="7.68" spread="3.063"/>
                    <measurement group_id="O3" value="7.68" spread="2.043"/>
                    <measurement group_id="O4" value="6.33" spread="5.275"/>
                    <measurement group_id="O5" value="8.00" spread="4.258"/>
                    <measurement group_id="O6" value="10.07" spread="4.294"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="9.98" spread="3.357"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="14.81" spread="4.365"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Area Under the Concentration-time Curve (AUC0 t)</title>
        <description>In the time interval from 0 to time (t) when the last blood sample is collected with a concentration above the limit of quantification.
C5: for the data of Day 14 based on measurements within 72 hours after the last dose administration</description>
        <time_frame>Up to 72 hours after the last drug administration</time_frame>
        <population>C1-4 - Single or double dose administration, C5 - Multiple administration for 14 days</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 1 (C1A+C1B), PBTZ169, Fasted</title>
            <description>PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
          </group>
          <group group_id="O2">
            <title>Cohort 1 (C1A+C1B), PBTZ169, After Meal</title>
            <description>PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
          </group>
          <group group_id="O3">
            <title>Cohort 2 (C2), PBTZ169</title>
            <description>Single dose of PBTZ169: 960 mg fasted
PBTZ169 960 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O4">
            <title>Cohort 3 (C3), PBTZ169</title>
            <description>Two doses of PBTZ169: 640 mg twice a day (fasted) with a 12-hour interval; total daily dose – 1280 mg
PBTZ169 640 mg BiD: Twice a day fasted; 1 day of administration</description>
          </group>
          <group group_id="O5">
            <title>Cohort 4 (C4), PBTZ169</title>
            <description>Single dose of PBTZ169: 1280 mg fasted
PBTZ169 1280 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O6">
            <title>Cohort 5 (C5), PBTZ169</title>
            <description>Multiple administration of PBTZ169: 1280 mg once a day after meal for 14 days
PBTZ169 1280 mg MD: Once a day after meals, 14 doses</description>
          </group>
        </group_list>
        <measure>
          <title>Area Under the Concentration-time Curve (AUC0 t)</title>
          <description>In the time interval from 0 to time (t) when the last blood sample is collected with a concentration above the limit of quantification.
C5: for the data of Day 14 based on measurements within 72 hours after the last dose administration</description>
          <population>C1-4 - Single or double dose administration, C5 - Multiple administration for 14 days</population>
          <units>ng*h/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Dosing day / Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="181.63" spread="112.236"/>
                    <measurement group_id="O2" value="575.19" spread="221.735"/>
                    <measurement group_id="O3" value="258.42" spread="174.149"/>
                    <measurement group_id="O4" value="342.03" spread="141.061"/>
                    <measurement group_id="O5" value="220.77" spread="124.754"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="1479.76" spread="459.066"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Area Under the Concentration-time Curve (AUC0-∞)</title>
        <description>In the time interval from 0 to infinity</description>
        <time_frame>Up to 72 hours after the last drug administration</time_frame>
        <population>C1-4 - Single or double dose administration, C5 - Multiple administration for 14 days</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 1 (C1A+C1B), PBTZ169, Fasted</title>
            <description>PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
          </group>
          <group group_id="O2">
            <title>Cohort 1 (C1A+C1B), PBTZ169, After Meal</title>
            <description>PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
          </group>
          <group group_id="O3">
            <title>Cohort 2 (C2), PBTZ169</title>
            <description>Single dose of PBTZ169: 960 mg fasted
PBTZ169 960 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O4">
            <title>Cohort 3 (C3), PBTZ169</title>
            <description>Two doses of PBTZ169: 640 mg twice a day (fasted) with a 12-hour interval; total daily dose – 1280 mg
PBTZ169 640 mg BiD: Twice a day fasted; 1 day of administration</description>
          </group>
          <group group_id="O5">
            <title>Cohort 4 (C4), PBTZ169</title>
            <description>Single dose of PBTZ169: 1280 mg fasted
PBTZ169 1280 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O6">
            <title>Cohort 5 (C5), PBTZ169</title>
            <description>Multiple administration of PBTZ169: 1280 mg once a day after meal for 14 days
PBTZ169 1280 mg MD: Once a day after meals, 14 doses</description>
          </group>
        </group_list>
        <measure>
          <title>Area Under the Concentration-time Curve (AUC0-∞)</title>
          <description>In the time interval from 0 to infinity</description>
          <population>C1-4 - Single or double dose administration, C5 - Multiple administration for 14 days</population>
          <units>ng*h/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Dosing day / Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="175.98" spread="104.828"/>
                    <measurement group_id="O2" value="584.06" spread="221.531"/>
                    <measurement group_id="O3" value="267.94" spread="175.918"/>
                    <measurement group_id="O4" value="348.56" spread="141.198"/>
                    <measurement group_id="O5" value="228.93" spread="124.855"/>
                    <measurement group_id="O6" value="1153.89" spread="482.189"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="1479.16" spread="594.599"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="1501.97" spread="483.483"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Area Under the Concentration-time Curve (AUC0-24)</title>
        <description>C5 (multiple administration once a day for 14 days): AUC0-24 was calculated based on measurements within 24 hours after PBTZ169 intake</description>
        <time_frame>In the dosing interval (up to 24 hours after drug administration)</time_frame>
        <population>C5 (multiple administration for 14 days) - AUC0-τ within 72 hours after the last (14th) dose administration</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 5 (C5), PBTZ169</title>
            <description>Multiple administration of PBTZ169: 1280 mg once a day after meal for 14 days
PBTZ169 1280 mg MD: Once a day after meals, 14 doses</description>
          </group>
        </group_list>
        <measure>
          <title>Area Under the Concentration-time Curve (AUC0-24)</title>
          <description>C5 (multiple administration once a day for 14 days): AUC0-24 was calculated based on measurements within 24 hours after PBTZ169 intake</description>
          <population>C5 (multiple administration for 14 days) - AUC0-τ within 72 hours after the last (14th) dose administration</population>
          <units>ng/ml*h</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1111.90" spread="463.267"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1374.48" spread="575.119"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1363.85" spread="450.006"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Clearance (Clt/F)</title>
        <time_frame>Up to 72 hours after the last drug administration</time_frame>
        <population>C1-4 - Single or double dose administration, C5 - Multiple administration for 14 days</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 1 (C1A+C1B), PBTZ169, Fasted</title>
            <description>PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
          </group>
          <group group_id="O2">
            <title>Cohort 1 (C1A+C1B), PBTZ169, After Meal</title>
            <description>PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
          </group>
          <group group_id="O3">
            <title>Cohort 2 (C2), PBTZ169</title>
            <description>Single dose of PBTZ169: 960 mg fasted
PBTZ169 960 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O4">
            <title>Cohort 3 (C3), PBTZ169</title>
            <description>Two doses of PBTZ169: 640 mg twice a day (fasted) with a 12-hour interval; total daily dose – 1280 mg
PBTZ169 640 mg BiD: Twice a day fasted; 1 day of administration</description>
          </group>
          <group group_id="O5">
            <title>Cohort 4 (C4), PBTZ169</title>
            <description>Single dose of PBTZ169: 1280 mg fasted
PBTZ169 1280 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O6">
            <title>Cohort 5 (C5), PBTZ169</title>
            <description>Multiple administration of PBTZ169: 1280 mg once a day after meal for 14 days
PBTZ169 1280 mg MD: Once a day after meals, 14 doses</description>
          </group>
        </group_list>
        <measure>
          <title>Total Clearance (Clt/F)</title>
          <population>C1-4 - Single or double dose administration, C5 - Multiple administration for 14 days</population>
          <units>l/h</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Dosing day / Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4910.09" spread="2711.818"/>
                    <measurement group_id="O2" value="1260.08" spread="491.974"/>
                    <measurement group_id="O3" value="8246.42" spread="12883.377"/>
                    <measurement group_id="O4" value="4185.23" spread="1507.230"/>
                    <measurement group_id="O5" value="6617.74" spread="2217.282"/>
                    <measurement group_id="O6" value="1302.31" spread="548.472"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="959.89" spread="269.654"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="924.97" spread="261.681"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Volume of Distribution (Vd/F)</title>
        <time_frame>Up to 72 hours after the last drug administration</time_frame>
        <population>C1-4 - Single or double dose administration, C5 - Multiple administration for 14 days</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 1 (C1A+C1B), PBTZ169, Fasted</title>
            <description>PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
          </group>
          <group group_id="O2">
            <title>Cohort 1 (C1A+C1B), PBTZ169, After Meal</title>
            <description>PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
          </group>
          <group group_id="O3">
            <title>Cohort 2 (C2), PBTZ169</title>
            <description>Single dose of PBTZ169: 960 mg fasted
PBTZ169 960 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O4">
            <title>Cohort 3 (C3), PBTZ169</title>
            <description>Two doses of PBTZ169: 640 mg twice a day (fasted) with a 12-hour interval; total daily dose – 1280 mg
PBTZ169 640 mg BiD: Twice a day fasted; 1 day of administration</description>
          </group>
          <group group_id="O5">
            <title>Cohort 4 (C4), PBTZ169</title>
            <description>Single dose of PBTZ169: 1280 mg fasted
PBTZ169 1280 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O6">
            <title>Cohort 5 (C5), PBTZ169</title>
            <description>Multiple administration of PBTZ169: 1280 mg once a day after meal for 14 days
PBTZ169 1280 mg MD: Once a day after meals, 14 doses</description>
          </group>
        </group_list>
        <measure>
          <title>Volume of Distribution (Vd/F)</title>
          <population>C1-4 - Single or double dose administration, C5 - Multiple administration for 14 days</population>
          <units>l</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Dosing day / Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33460.07" spread="19725.828"/>
                    <measurement group_id="O2" value="13475.58" spread="6895.800"/>
                    <measurement group_id="O3" value="67278.30" spread="61222.530"/>
                    <measurement group_id="O4" value="34649.86" spread="29430.057"/>
                    <measurement group_id="O5" value="77814.43" spread="50236.867"/>
                    <measurement group_id="O6" value="21126.27" spread="15900.286"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="13745.97" spread="5520.697"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="19411.17" spread="6813.126"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Elimination Constant Kel</title>
        <time_frame>Up to 72 hours after the last drug administration</time_frame>
        <population>C1-4 - Single or double dose administration, C5 - Multiple administration for 14 days</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 1 (C1A+C1B), PBTZ169, Fasted</title>
            <description>PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
          </group>
          <group group_id="O2">
            <title>Cohort 1 (C1A+C1B), PBTZ169, After Meal</title>
            <description>PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
          </group>
          <group group_id="O3">
            <title>Cohort 2 (C2), PBTZ169</title>
            <description>Single dose of PBTZ169: 960 mg fasted
PBTZ169 960 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O4">
            <title>Cohort 3 (C3), PBTZ169</title>
            <description>Two doses of PBTZ169: 640 mg twice a day (fasted) with a 12-hour interval; total daily dose – 1280 mg
PBTZ169 640 mg BiD: Twice a day fasted; 1 day of administration</description>
          </group>
          <group group_id="O5">
            <title>Cohort 4 (C4), PBTZ169</title>
            <description>Single dose of PBTZ169: 1280 mg fasted
PBTZ169 1280 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O6">
            <title>Cohort 5 (C5), PBTZ169</title>
            <description>Multiple administration of PBTZ169: 1280 mg once a day after meal for 14 days
PBTZ169 1280 mg MD: Once a day after meals, 14 doses</description>
          </group>
        </group_list>
        <measure>
          <title>Elimination Constant Kel</title>
          <population>C1-4 - Single or double dose administration, C5 - Multiple administration for 14 days</population>
          <units>1/h</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Dosing day / Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1765" spread="0.1067"/>
                    <measurement group_id="O2" value="0.1027" spread="0.0356"/>
                    <measurement group_id="O3" value="0.0993" spread="0.0396"/>
                    <measurement group_id="O4" value="0.1865" spread="0.1175"/>
                    <measurement group_id="O5" value="0.1154" spread="0.0682"/>
                    <measurement group_id="O6" value="0.0866" spread="0.0501"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="0.0765" spread="0.0240"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O6" value="0.0512" spread="0.0180"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Relative Bioavailability</title>
        <description>f=AUC0-∞(T)/AUC0-∞(R); f'=AUC0-t(T)/AUC0-t(R) Test (T) - PBTZ169 640 mg after meals, reference (R) - PBTZ169 640 mg fasted</description>
        <time_frame>Up to 72 hours after the last drug administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cohort 1 (C1A+C1B), PBTZ169, &quot;After Meals (T)&quot;/&quot;Fasted (R)&quot;</title>
            <description>PBTZ169 640 mg OD: Two administrations once a day with a wash-out period (cross-over): food effect</description>
          </group>
        </group_list>
        <measure>
          <title>Relative Bioavailability</title>
          <description>f=AUC0-∞(T)/AUC0-∞(R); f'=AUC0-t(T)/AUC0-t(R) Test (T) - PBTZ169 640 mg after meals, reference (R) - PBTZ169 640 mg fasted</description>
          <units>% of T/R geometric mean ratio</units>
          <param>Geometric Mean</param>
          <dispersion>90% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>f</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="344.54" lower_limit="293.99" upper_limit="403.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>f’</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="350.20" lower_limit="300.94" upper_limit="407.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Relative Degree of Absorption</title>
        <description>f&quot;=Cmax(T)/Cmax(R). Test (T) - PBTZ169 640 mg after meals, reference (R) - PBTZ169 640 mg fasted</description>
        <time_frame>Up to 72 hours after the last drug administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cohort 1 (C1A+C1B), PBTZ169, &quot;After Meals (T)&quot;/&quot;Fasted (R)&quot;</title>
            <description>PBTZ169 640 mg OD: Two administrations once a day with a wash-out period (cross-over): food effect</description>
          </group>
        </group_list>
        <measure>
          <title>Relative Degree of Absorption</title>
          <description>f&quot;=Cmax(T)/Cmax(R). Test (T) - PBTZ169 640 mg after meals, reference (R) - PBTZ169 640 mg fasted</description>
          <units>geometric mean ratio, %</units>
          <param>Geometric Mean</param>
          <dispersion>90% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="229.03" lower_limit="179.29" upper_limit="292.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Subjects With CS Changes in Vital Signs</title>
        <description>Safety and tolerability: No. of sbjs with clinically significant changes in vital signs (blood pressure, HR, body temperature, RR)</description>
        <time_frame>Up to last visit time point: C2, C3, C4 up to Day 7; C1 up to Day 13; C5 up to Day 21 after first drug intake</time_frame>
        <population>Safety population</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 1 (C1A), PBTZ169</title>
            <description>Two doses of PBTZ169: 640 mg OD fasted and 640 mg OD after meal. Wash-out period ≥6 days.
PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
          </group>
          <group group_id="O2">
            <title>Cohort 1 (C1B), PBTZ169</title>
            <description>Two doses of PBTZ169: 640 mg OD after meal and 640 OD mg fasted. Wash-out period ≥6 days.
PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
          </group>
          <group group_id="O3">
            <title>Cohort 2 (C2), PBTZ169</title>
            <description>Single dose of PBTZ169: 960 mg fasted
PBTZ169 960 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O4">
            <title>Cohort 3 (C3), PBTZ169</title>
            <description>Two doses of PBTZ169: 640 mg twice a day (fasted) with a 12-hour interval; total daily dose – 1280 mg
PBTZ169 640 mg BiD: Twice a day fasted; 1 day of administration</description>
          </group>
          <group group_id="O5">
            <title>Cohort 4 (C4), PBTZ169</title>
            <description>Single dose of PBTZ169: 1280 mg fasted
PBTZ169 1280 mg SD: Once a day fasted</description>
          </group>
          <group group_id="O6">
            <title>Cohort 5 (C5), PBTZ169</title>
            <description>Multiple administration of PBTZ169: 1280 mg once a day after meal for 14 days
PBTZ169 1280 mg MD: Once a day after meal, 14 doses</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With CS Changes in Vital Signs</title>
          <description>Safety and tolerability: No. of sbjs with clinically significant changes in vital signs (blood pressure, HR, body temperature, RR)</description>
          <population>Safety population</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CS Blood pressure deviations</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS Sinus tachycardia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS Temperature changes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS RR changes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Single and double dosing groups - up to 5 ± 1 days after the last PBTZ169 dose intake (Cohorts 1-4): C1A, C1B - up to Day 12 ± 1 (Day 1 - 1st dosing day) C2, C3, C4 - up to Day 6 ± 1 (Day 1 - dosing day) Multiple dosing group - up to 7 ± 1 days after the last PBTZ169 dose intake (Cohort 5): C5 - up to Day 21±1 (Day 1 - 1st dosing day)</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Cohort 1 (C1A+C1B), PBTZ169</title>
          <description>Two doses of PBTZ169: 640 mg OD fasted/after meal and 640 mg OD after meal/fasted. Wash-out period ≥6 days.
PBTZ169 640 mg OD: Two administrations once a day with a wash-out period: food effect</description>
        </group>
        <group group_id="E2">
          <title>Cohort 2 (C2), PBTZ169</title>
          <description>Single dose of PBTZ169: 960 mg fasted
PBTZ169 960 mg SD: Once a day fasted</description>
        </group>
        <group group_id="E3">
          <title>Cohort 3 (C3), PBTZ169</title>
          <description>Two doses of PBTZ169: 640 mg twice a day (fasted) with a 12-hour interval; total daily dose – 1280 mg
PBTZ169 640 mg BiD: Twice a day fasted; 1 day of administration</description>
        </group>
        <group group_id="E4">
          <title>Cohort 4 (C4), PBTZ169</title>
          <description>Single dose of PBTZ169: 1280 mg fasted
PBTZ169 1280 mg SD: Once a day fasted</description>
        </group>
        <group group_id="E5">
          <title>Cohort 5 (C5), PBTZ169</title>
          <description>Multiple administration of PBTZ169: 1280 mg once a day after meal for 14 days
PBTZ169 1280 mg MD: Once a day after meal, 14 doses</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA 20.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Sinus tachycardia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Defect conduction intraventricular</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood glucose increased</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Electrocardiogram abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Electrocardiogram repolarisation abnormality</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hypercreatininaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E5" events="2" subjects_affected="1" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Viсtoria Shcherbakova</name_or_title>
      <organization>Nearmedic Plus</organization>
      <phone>+7 (495) 741 49 89 ext 3869</phone>
      <email>Viktoriya.Shcherbakova@nearmedic.ru</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

